OTOzge Turna

Ozge Turna

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ozge Turna has a total of 52 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • In vitro effects of sodium butyrate, a histone deacetylase inhibitor on canine mammary tumour subtypes

    by Ozge Turna, Asuman Deveci Ozkan, Gamze Guney Eskiler, Aslıhan Baykal, Gulay Yuzbasioglu Ozturk

    Malignant canine mammary tumours (CMTs) are subdivided as carcinomas (C), sarcomas (S) and carcinosarcomas (CS) according to their histological type. Due to the varying responses to different treatments, novel therapeutic approaches are required. Sodium butyrate (NaBu) is the first histone deacetylase inhibitor and exhibits anti-cancer activity in different types of human cancers. However, no study is available in the literature evaluating the effects of NaBu on CMT cells. Therefore, for the first time, we aimed to investigate the in vitro efficacy of NaBu on three subtypes of CMT cells. Primary cells were isolated from neoplastic tissues of three dogs with CMT. Cell viability, apoptotic percentage and changes in the cell morphology, apoptosis-associated gene and protein expression levels were evaluated. Our findings showed that NaBu decreased the growth of the cells and increased the percentage of apoptosis in three subtypes of CMT cells. Additionally, NaBu treatment affected the expression levels of genes and proteins associated with apoptosis, especially in S cells. Our preliminary results, for the first time, revealed the efficacy of NaBu in CMT cells and the importance of the histological subtype in NaBu response. However, the molecular classification of CMT and the underlying mechanisms of the different NaBu responses should be further investigated.

  • Comparison of the anti-cancer activity of 5-aminolevulinic acid-mediated photodynamic therapy after continuous wave and pulse irradiation in different histological types of canine mammary sarcoma tumors

    by Ozge Turna, Asuman Deveci Ozkan, Gamze Guney Eskiler, Aslihan Baykal, Ozge Ozten, Funda Yildirim, Elif Ilkay Armutak, Ali Furkan Kamanli, Hyun Soo Lim, Suleyman Kaleli, et al.

    Canine mammary sarcoma tumors (CMST) are the most aggressive tumors with poor prognosis in dogs. Due to inadequate treatment options for CMST, recent studies have focused on alternative treatment strategies. We previously determined the optimized protocol of 5-ALA-based photodynamic therapy (PDT) in canine liposarcoma. However, its molecular mechanisms in the treatment of different histological types of CMST remain unclear. In this context, we, for the first time, assessed 5-aminolevulinic acid (5-ALA)-PDT–mediated anti-cancer activity and its molecular mechanism after continuous wave (CW) and pulse radiation (PR) on three different histological types (liposarcoma, chondrosarcoma, and osteosarcoma) of CMST cells by WST-1, Annexin V, ROS, acridine orange/propidium iodide staining, RT-PCR, and western blot analysis. Our findings showed that 5-ALA/PDT significantly suppressed the proliferation of CMST cells (p < 0.01) and induced apoptosis via increased ROS level and overexpression of Caspase-9 and Caspase-3 mRNA and cleaved protein levels in especially liposarcoma and chondrosarcoma cells following CW and PR irradiation at 9 J/cm2. However, the response of CMST cells to 5-ALA was different upon CW and PR irradiation due to differences in their origin. Collectively, our findings provided the first evidence that 5-ALA-based PDT could be used as an alternative treatment strategy, especially liposarcoma and chondrosarcoma. However, further in vitro and in vivo studies are required to elucidate the underlying molecular mechanism of the efficacy of 5-ALA in CMST cells at the molecular level.


  • The response of the canine mammary simple carcinoma and carcinosarcoma cells to 5-aminolaevulinic acid-based photodynamic therapy: An in vitro study

    by Gamze Guney Eskiler, Ozge Turna, Asuman Deveci Ozkan, Aslihan Baykal, Hazal Ozturk Gurgen, Beyzanur Erk, Elif Ilkay Armutak, Hyun Soo Lim


  • Evidence for heterogeneity in response to treatment in mammary tumors of dogs as happens in humans

    by Ozge Turna, Ayca Uvez, Aslihan Baykal, Elif Sedef Develi, Murat Diramali, Kivilcim Sonmez, Didem Karakas, Guven Kasikci, Elif Ilkay Armutak, Engin Ulukaya

    Tumors are formed by various clones developed over a long time. This gives rise to a heterogeneous nature. This heterogeneity is the hardest challenge in the treatment of cancers because it is the main reason for drug resistance. This is a well-known fact in human cancer. Therefore, we have reasoned that if the tumor heterogeneity in canine mammary gland tumors (CMGTs) could be shown by an ex vivo assay, which will be used first time in veterinary oncology practice, this could be used further in clinics. To achieve this, twenty-six patients were included in the study. Tumor tissues were obtained from animals during routine surgery. Tumor cells were isolated and seeded ex vivo. The cells were exposed to anticancer drugs that are clinically used. Seven days after the treatment, chemosensitivity has luminometrically been assayed by ATP-tumor chemosensitivity assay (ATP-TCA). It has clearly been shown that all the tumor tissues have responded to treatment differently, implying that heterogeneity exists in mammary tumors. There has also been found that there was a weak to moderate statistically significant correlation between tumor size and drug index. However, there has been no correlation between drug index and metastasis to lymph nodes. Hyperplasic areas had relatively higher PCNA values. The results of our study demonstrate the heterogeneity in responses to in vitro drugs. Clinical trials based on test results and follow-up studies with large numbers of animals are needed to prove that such chemotherapeutic activity assessment tests can be clinically useful in predicting drug responses in CMGTs.


  • Open Access

    Determination of the Apoptotic Effect of Raf2 and Nck-Interacting Protein Kinase Inhibitor on Metastatic Canine Mammary Gland Tumor Cells

    by Asuman Deveci̇ Özkan, Ayten Haciefendi̇, Fatih Özkan, Gamze Güney Eski̇ler, Süleyman Kaleli̇, Ecir Ali Çakmak, Özge Turna

    Objective: Canine mammary gland tumors (CMGTs) are the most common tumors in female dogs and the main treatment options used in CMGTs are surgery caused some complications. Therefore, new treatment options are needed for the CMGTs. Traf2 and Nck-interacting serine protein kinase (TNIK) as a transcriptional coregulator of Wnt targeted genes is highly expressed in breast cancer development. The inhibition of TNIK may be a new therapeutic target in cancers with abnormal WNT signaling. Therefore we aimed to investigate the potential therapeutic effect of NCB-0846 on metastatic sarcoma CMGTs subtype, for the first time. Materials and Methods: The cytotoxic and apoptotic effects of NCB-0846 on CMGT cells were analyzed by WST‑1, Annexin V, cell cycle, acridine orange (AO) and DAPI staining. Results: NCB-0846 significantly inhibited cell viability in a dose and time dependent manner (p<0.05) and induced nuclear damage in CMGT cells. Furthermore, NCB-0846 caused apoptotic cell death through the accumulation of cells in the G0/G1 phase. Conclusion: Our findings demonstrated that NCB-0846 could be potentially a new therapeutic anti-cancer agent in the treatment of CMGTs. However, further investigations need to be performed in order to elucidate the inhibitory activity of TNIK and Wnt signaling by NCB-0846 on CMGT cells.

  • The anti-proliferative and apoptotic effects of curcumin on feline mammary gland tumor cells in vitro

    by A. Deveci Ozkan, G. Guney Eskiler, O. Turna, N. Kazan, E. Sozen Kucukkara, A. Baykal, K. Sonmez

    Feline mammary gland tumors (FMGTs) are the third most diagnosed tumors in cats. Feline mammary gland tumors have aggressive biological behavior and poor response to both surgical and medical treatments, thus, new therapeutic approaches are essential to improve. Curcumin (CUR) is a polyphenol component exhibiting anti-cancer effects and induces apoptosis through different mechanisms especially in human breast cancer. However, there is no study investigating the effects of CUR on FMGTs. The aim of this study was to determine the anti-proliferative and apoptotic effects of CUR on primary cell lines from FMGT tissue samples of two cases classified as carcinoma-simple, tubular type (grade III). The cytotoxic effect of CUR was determined by water-soluble tetrazolium salt-1 (WST-1) assay. Annexin V, cell cycle, and acridine orange (AO) analyses were performed to determine the apoptotic effect of CUR. Our results showed that CUR had an anti-proliferative and apoptotic effect through induction of apoptosis and cell cycle arrest (G0/G1) on FMGT cells. Therefore, this is the first study that shows the effects of CUR on FMGTs. However, further molecular studies are required to compare the effects of CUR on different histopathological phenotypes and to determine the further molecular mechanisms including the potential apoptotic and cellular pathways affected by CUR.


  • Open Access

    Current invasive and non-invasive biomarkers in canine mammary tumors

    by Aslihan Baykal, Özge Turna

    In bitches, the incidence of mammary tumors is determined at %50 of all neoplasms. Most of the cases are malignant and tend to metastasize. Because of this, early diagnosis has an important value. Due to the molecular and clinical similarities of canine mammary tumors to human breast cancers, human breast cancer markers are also detectable in cases of canine mammary tumors. Generally, biomarkers provide information about criteria such as clinical diagnosis, early diagnosis, prognosis, and determination of the treatment protocol. When choosing the appropriate biomarker, it should be taken into account that it is easy to apply, has a positive correlation with tumor specificity and malignancy, and whether gives precise information about prognosis. Due to the heterogeneous nature of canine mammary tumors, an ideal biomarker has not determined yet. However, new studies have revealed the existence of many biomarkers. In this review it is given to qualified and current biomarkers can be used in dogs, including invasive and non-invasive mammary tumor biomarkers.


  • Open Access

    Changes in Doppler indices throughout pregnancy in queens

    by Melih Uçmak, Özge Turna, Gamze Evkuran Dal, Zeynep Günay Uçmak, Mehmet Can Gündüz

    Doppler ultrasonography (D-USG) is a non-invasive technique that has become an increasingly essential tool in veterinary theriogenology. The aim of this study was to evaluate the changes of Doppler indices in the foetal aorta (FA), foetal vena cava (FVC), umbilical artery (UA), and uteroplacental artery (UPA) in pregnant queens, thereby advancing knowledge about Doppler findings in normal feline pregnancy. The study was conducted with 10 pregnant queens with known gestational age. Doppler ultrasonography was performed every three days beginning from the 21 st day to the 60 th day of pregnancy. The pulsatility index (PI) and resistance index (RI) of FA, FVC, UA and UPA were recorded during the D-USG examinations. Although a declining trend was seen in the mean RI of FA, a comparison with earlier sampling periods revealed that significant decreases ( P < 0.05) did not occur until Days 30 and 60. While PI of FVC was relatively constant, RI varied througout pregnancy. The PI and RI of UPA values were significantly lower ( P < 0.05) on Day 60 when compared to the first five sampling periods for PI and the first six sampling periods for RI. The study concludes that the decrease in UA indices is a precursor for delivery time in queens. However, there is a need for further comparative studies involving impaired pregnancies.